Clinical Application of CAR T Cells


Chimeric antigen receptor (CAR) T-cell (’Living Drug’) immunotherapy is showing promising results in the treatment of cancers.  There are nine ongoing clinical trials (Phase I & II) at  Memorial Sloan Kettering (MSK) and more on track to be initiated next year.

Over the years, MSK has accumulated a breadth of knowledge about developing and translating these clinical trials from bench to bedside – choosing the ideal antigen target, constructing clinical grade CARs and vectors, investigating in clinically relevant models, manufacturing, quality control, developing protocols for FDA approval, optimizing consent forms covering emerging ethical issues, managing complications, and conducting world-class correlative science.

In addition to the MSK faculty, national and international experts will discuss clinical and translational aspects of CARs, both for hematological malignancies and solid tumors.


The target audience is medical oncologists and oncology fellows in training, basic scientists and research fellows in training, immunologists, and surgeons with interest in tumor immunology and immunotherapy.


Memorial Sloan Kettering Cancer Center designates this conference for a maximum of 12.75 AMA PRA Category 1 Credits™. Each physician should claim only those hours of credit he/she actually spent in the conference.

Additional Information

See brochure for course details.

Call for Abstracts

We are pleased to invite you to submit an Abstract for presentation at the CAR T-Cell CME Course. Abstracts for the poster session will be selected on the basis of their scientific merit and content quality.  Selected abstracts will be awarded travel awards.  All Abstracts must be submitted to Memorial Sloan Kettering Cancer Center by Friday, February 5, 2016.  Please click here to submit an Abstract.

Date & Time(s)


Memorial Sloan Kettering Cancer Center
Zuckerman Research Center
417 East 68th Street
(between First and York Avenues)
New York, NY 10065


646-227-2025 (Phone)
212-557-0773 (Fax)


Memorial Sloan Kettering Cancer Center

Registration Details

Cancellation Policy

If you register for a MSK CME course and need to cancel your registration, please let us know by email at or by telephone at 646-227-2025.  Up until the day before the course, you can receive a refund of your registration fee minus a $65 processing fee.  At any time, you may substitute another registrant in your place after contacting the CME Office with the relevant information.


Keynote Speakers

Zelig Eshhar, PhD
Professor of Immunology
The Weizmann Institute of Science, Israel

Michel Sadelain, MD, PhD 
Director, Center for Cell Engineering
Memorial Sloan Kettering Cancer Center

MSK Faculty

  • Prasad S. Adusumilli, MD, Thoracic Surgery 
  • Renier J. Brentjens, MD, PhD, Leukemia 
  • Kevin J. Curran, MD, Pediatrics 
  • Sergio A. Giralt, MD, Chief, Bone Marrow Transplant 
  • Roisin E. O’Cearbhaill, MD, Gynecologic Medicine 
  • Jae Park, MD, Leukemia 
  • Isabelle Riviere, PhD, Cell Therapy & Cell Engineering 
  • Paul Sabbatini, MD, Deputy Physician-in-Chief 
  • Michel Sadelain, MD, PhD, Center for Cell Engineering 
  • Craig S. Sauter, MD, Bone Marrow Transplant 
  • David A. Scheinberg, MD, PhD, Chair, Molecular Pharmacology Program
  • Marcel R.M. van den Brink, MD, PhD, Division Head, Hematologic Oncology – Medicine
  • Roger S. Wilson, MD, Institutional Review Board
  • Jedd D. Wolchok, MD, PhD, Chief, Melanoma and Immunotherapeutics

Invited Faculty

  • Steven M. Albelda, MD, University of Pennsylvania
  • Christine Brown, PhD, City of Hope
  • Laurence J. N. Cooper, MD, PhD, MD Anderson
  • Marco L. Davila, MD, PhD, Moffitt Cancer Center
  • Soldano Ferrone, MD, PhD, Massachusetts General Hospital
  • Noelle Frey, MD, MSCE, University of Pennsylvania
  • Rebecca A. Gardner, MD, Seattle Children’s Hospital
  • Adrian P. Gee, PhD, Baylor Medical Center
  • David Gilham, PhD, University of Manchester
  • Zelig Eshhar, PhD, The Weizmann Institute of Science, Israel
  • Stephen Gottschalk, MD, Baylor Medical Center
  • Michael C. V. Jensen, MD, Seattle Children’s Hospital
  • James N. Kochenderfer, MD, National Cancer Institute
  • Daniel W. Lee, MD, National Cancer Institute
  • Bruce L. Levine, PhD, University of Pennsylvania
  • John Maher, PhD, FRCPath, King’s College London
  • Shannon L. Maude, MD, PhD, Children’s Hospital of Philadelphia
  • Marcela V. Maus, MD, PhD, Massachusetts General Hospital
  • David L. Porter, MD, University of Pennsylvania
  • Stephen J. Schuster, MD, University of Pennsylvania
  • Cameron J. Turtle, MD, PhD, Fred Hutchinson Cancer Center

Course Director

Prasad S. Adusumilli, MD, FACS, FCCP
Member, Center for Cell Engineering and Center for Cellular Therapeutics
Deputy Chief, Thoracic Surgery Service

Course Co-Director

Renier Brentjens, MD, PhD
Director, Center for Cellular Therapeutics

Michel Sadelain, MD, PhD
Director, Center for Cell Engineering 



Online payment is no longer available.